By binding BamA, bicyclic heptapeptides bypass Gram-negative membrane barriers and kill pathogens while enabling faster, higher-yield production.
Histidine-engineered immunoglobulin sequences enable pH-dependent antigen release, improving antibody recycling and serum half-life.
Two plant glucosyltransferases are paired to raise rebaudioside A to M conversion, improving enzymatic sweetener production.
Recombinase-flanked coding sequences enable selective polypeptide expression in defined cell sub-populations for precise neuronal control and monitoring.
Hydroxylated polyamine derivatives balance hydrophobic uptake and complex stability to improve RNA transfection across diverse cell types.
Prepackaged baculovirus gene delivery and low-MOI co-infection help insect cells produce high-titer rAAV while limiting gene loss.
Engineered gene circuits sense tumor metabolite D-2-HG to trigger transgene expression, improving IDH-mutant tumor detection and targeted cell response.
Gene trap vectors in near-haploid mammalian cells enable direct screening of recessive mutations and phenotype-linked genes.
By inserting endonuclease sites between promoter regions, this case lowers lacZα expression to avoid host toxicity and cloning false calls.
Targeted mutations at luciferase positions 26 and 161 raise luminescence intensity for clearer autonomous molecular imaging.
A Chinese hamster artificial chromosome enables site-directed DNA insertion in CHO cells to maintain stable antibody expression over long-term culture.
Engineered anti-CD3 binding reduces excessive T cell activation and cytokine toxicity while supporting flexible bispecific antibody design.
Split AAV genomes use recombinase-mediated joining to deliver large genes like ABCA4 beyond the 4.7 kb packaging limit.
Engineered mannanase variants retain activity across pH 5-12 and surfactant-rich detergents to remove mannan stains and prevent fabric graying.
Histidine substitutions in animal immunoglobulin loci create antibodies that release antigens at acidic pH, improving recycling and serum half-life.
Engineered heterologous enzymes let recombinant cells make pN-Phe from native metabolites and incorporate it into proteins without external supplementation.
AAV delivery of codon-optimized Factor IX maintains stable clotting activity to prevent hemophilic joint bleeding and arthropathy.
Short recombinant polyA sequences maintain high multigene expression while lowering vector size and recombination risk in eukaryotic cells.
A ROR-1-binding CAR with tuned signaling domains and spacer design improves immune cell specificity and therapeutic efficacy against proliferative disorders.